Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Stem cell composition for preventing and treating diabetic foot and its use, and a stem cell preparation

A stem cell preparation and stem cell technology are applied in the field of stem cells to achieve the effects of simple separation, less damage to the donor site, and improved microenvironment

Inactive Publication Date: 2017-12-08
GUANGZHOU SALIAI STEMCELL SCI & TECH CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] So far, there is no report on the combination of mesenchymal stem cells and peripheral blood mononuclear cells in the treatment of ischemic diabetic foot

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stem cell composition for preventing and treating diabetic foot and its use, and a stem cell preparation
  • Stem cell composition for preventing and treating diabetic foot and its use, and a stem cell preparation
  • Stem cell composition for preventing and treating diabetic foot and its use, and a stem cell preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] Embodiment 1 The cultivation and collection of umbilical cord mesenchymal stem cells

[0044] (1) Under sterile conditions, take fresh umbilical cords that have been away from the mother for no more than 2 hours, and screen whether the mother is carrying infectious disease pathogens. Negative) fresh umbilical cords were placed in PBS containing double antibodies and transported back to the laboratory in a 4°C incubator;

[0045] (2) Clean the fresh umbilical cord with sterile PBS, then disinfect it with 75% ethanol, and then clean it with PBS. After static and arterial, cut the umbilical cord to 20mm 3 Evenly inoculate the pieces with the size of 0.5 ~ 1cm in the petri dish, slowly add 50 ~ 100μl / cm 2 complete medium at 37°C, CO 2 Static culture in an incubator with a concentration of 5%;

[0046] (3) After the cells adhered to the wall and fused, they were digested with trypsin, centrifuged, and divided into multiple culture dishes for subculture.

Embodiment 2

[0047] Example 2 Culture and Collection of Bone Marrow Mesenchymal Stem Cells

[0048] (1) Under sterile conditions, transfer the patient's bone marrow tissue extracted by bone marrow puncture into a 50ml centrifuge tube, add DMEM-LG medium to dilute and mix, and then centrifuge at 500rpm / min for 10min. After centrifugation, absorb the fat in the upper layer and discard the supernatant;

[0049] (2) Add DMEM-LG medium to the remaining precipitate to dilute and mix it evenly, and add it along the tube wall to a test tube containing Ficoll lymphatic separation solution equal to the volume of the remaining precipitate, and centrifuge at 2200rpm / min for 30min. Collect the mononuclear cells in the mist layer after centrifugation, transfer to a new 50mL centrifuge tube, add PBS to wash the cells, discard the supernatant after centrifugation, and adjust the cell density to 2×10 5 cell / ml inoculated in a petri dish, placed at 37°C, CO 2 Static culture in an incubator with a concentrat...

Embodiment 3

[0051] Example 3 Culture and collection of adipose-derived mesenchymal stem cells

[0052] (1) Aliquot the adipose tissue extracted under aseptic conditions into 50ml centrifuge tubes, 20ml in each tube. Add an equal volume of 0.5% type Ⅰ collagenase (final concentration: 0.25%) to each tube, mix thoroughly, seal, transfer to a constant temperature air shaker, and digest for 1 hour at 37°C and 100rpm. Add 4ml FBS to each tube to stop digestion and mix well. Centrifuge at 1500rpm / min for 5min. Discard the upper two layers of liquid, add 40ml PBS to each tube to resuspend the cells, count manually and collect by centrifugation. Discard the supernatant and divide the cells at 1 x 10 5 cells / ml inoculated in a petri dish, placed at 37°C, CO 2 The concentration was 5% in the incubator for static culture.

[0053] (2) Change the medium for the first time after 24 hours, discard the suspended cells, and then change the medium every three days. When the cell confluency reached 8...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the field of stem cell technology, and in particular, to a stem cell composition for preventing and treating diabetic foot and its use, and a stem cell preparation. The stem cell composition consists of mesenchymal stem cells and peripheral blood mononuclear cells. The stem cell composition of the invention can effectively prevent and treat diabetic foot, and is better than single use of stem cells or peripheral blood mononuclear cells. The synergistic effect of the combined use of mesenchymal stem cells and peripheral blood mononuclear cells is achieved.

Description

technical field [0001] The invention relates to the technical field of stem cells, in particular to a stem cell composition for preventing and treating diabetic foot, an application thereof, and a stem cell preparation. Background technique [0002] In recent years, with the accelerated aging of the world's population, the number of diabetic patients has increased dramatically, seriously affecting the quality of life of individuals. The hazards of diabetes largely stem from its various complications, among which ischemic diabetic foot is one of the most common and serious complications, and because of its high mortality rate, amputation rate and infection rate, It is a common cause of disability and death in diabetic patients. The main clinical manifestations of diabetic foot are intermittent claudication, rest pain, foot ulcer and gangrene, which not only cause pain to patients, but also bring huge economic burden to society and family. [0003] For a long time, the treat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/28A61P3/10A61P17/02A61K35/15
CPCA61K35/28A61K2239/38A61K39/46433A61K39/4621A61K39/461A61K2239/31A61K2300/00
Inventor 陈海佳葛啸虎王一飞陈婉玲王小燕马岩岩罗二梅
Owner GUANGZHOU SALIAI STEMCELL SCI & TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products